Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Correction for Sandai et al., The Evolutionary Rewiring of Ubiquitination Targets Has Reprogrammed the Regulation of Carbon Assimilation in the Pathogenic Yeast Candida albicans.

Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, Bohovych I, Ene IV, Kastora S, Budge S, Munro CA, Odds FC, Gow NA, Brown AJ.

MBio. 2015 Jan 20;6(1). pii: e02489-14. doi: 10.1128/mBio.02489-14. No abstract available.

2.

New Clox Systems for rapid and efficient gene disruption in Candida albicans.

Shahana S, Childers DS, Ballou ER, Bohovych I, Odds FC, Gow NA, Brown AJ.

PLoS One. 2014 Jun 18;9(6):e100390. doi: 10.1371/journal.pone.0100390. eCollection 2014.

3.

Role of the Candida albicans MNN1 gene family in cell wall structure and virulence.

Bates S, Hall RA, Cheetham J, Netea MG, MacCallum DM, Brown AJ, Odds FC, Gow NA.

BMC Res Notes. 2013 Jul 26;6:294. doi: 10.1186/1756-0500-6-294.

4.

The Mnn2 mannosyltransferase family modulates mannoprotein fibril length, immune recognition and virulence of Candida albicans.

Hall RA, Bates S, Lenardon MD, Maccallum DM, Wagener J, Lowman DW, Kruppa MD, Williams DL, Odds FC, Brown AJ, Gow NA.

PLoS Pathog. 2013;9(4):e1003276. doi: 10.1371/journal.ppat.1003276. Epub 2013 Apr 25.

5.

Reporters for the analysis of N-glycosylation in Candida albicans.

Shahana S, Mora-Montes HM, Castillo L, Bohovych I, Sheth CC, Odds FC, Gow NA, Brown AJ.

Fungal Genet Biol. 2013 Jul;56:107-15. doi: 10.1016/j.fgb.2013.03.009. Epub 2013 Apr 19.

6.

The evolutionary rewiring of ubiquitination targets has reprogrammed the regulation of carbon assimilation in the pathogenic yeast Candida albicans.

Sandai D, Yin Z, Selway L, Stead D, Walker J, Leach MD, Bohovych I, Ene IV, Kastora S, Budge S, Munro CA, Odds FC, Gow NA, Brown AJ.

MBio. 2012 Dec 11;3(6). pii: e00495-12. doi: 10.1128/mBio.00495-12. Erratum in: MBio. 2015;6(1). pii: e02489-14. doi: 10.1128/mBio.02489-14.

7.

MAPKKK-independent regulation of the Hog1 stress-activated protein kinase in Candida albicans.

Cheetham J, MacCallum DM, Doris KS, da Silva Dantas A, Scorfield S, Odds F, Smith DA, Quinn J.

J Biol Chem. 2011 Dec 9;286(49):42002-16. doi: 10.1074/jbc.M111.265231. Epub 2011 Oct 12.

8.

Elevated cell wall chitin in Candida albicans confers echinocandin resistance in vivo.

Lee KK, Maccallum DM, Jacobsen MD, Walker LA, Odds FC, Gow NA, Munro CA.

Antimicrob Agents Chemother. 2012 Jan;56(1):208-17. doi: 10.1128/AAC.00683-11. Epub 2011 Oct 10.

9.

European expert opinion on the management of invasive candidiasis in adults.

Kullberg BJ, Verweij PE, Akova M, Arendrup MC, Bille J, Calandra T, Cuenca-Estrella M, Herbrecht R, Jacobs F, Kalin M, Kibbler CC, Lortholary O, Martino P, Meis JF, Muñoz P, Odds FC, De Pauw BE, Rex JH, Roilides E, Rogers TR, Ruhnke M, Ullmann AJ, Uzun Ö, Vandewoude K, Vincent JL, Donnelly JP.

Clin Microbiol Infect. 2011 Sep;17 Suppl 5:1-12. doi: 10.1111/j.1469-0691.2011.03615.x.

10.

Recognition and blocking of innate immunity cells by Candida albicans chitin.

Mora-Montes HM, Netea MG, Ferwerda G, Lenardon MD, Brown GD, Mistry AR, Kullberg BJ, O'Callaghan CA, Sheth CC, Odds FC, Brown AJ, Munro CA, Gow NA.

Infect Immun. 2011 May;79(5):1961-70. doi: 10.1128/IAI.01282-10. Epub 2011 Feb 28.

11.

Glycosylation status of the C. albicans cell wall affects the efficiency of neutrophil phagocytosis and killing but not cytokine signaling.

Sheth CC, Hall R, Lewis L, Brown AJ, Odds FC, Erwig LP, Gow NA.

Med Mycol. 2011 Jul;49(5):513-24. doi: 10.3109/13693786.2010.551425. Epub 2011 Jan 24.

12.

Differential regulation of kidney and spleen cytokine responses in mice challenged with pathology-standardized doses of Candida albicans mannosylation mutants.

Castillo L, MacCallum DM, Brown AJ, Gow NA, Odds FC.

Infect Immun. 2011 Jan;79(1):146-52. doi: 10.1128/IAI.01004-10. Epub 2010 Nov 8.

13.

An insight into the antifungal pipeline: selected new molecules and beyond.

Ostrosky-Zeichner L, Casadevall A, Galgiani JN, Odds FC, Rex JH.

Nat Rev Drug Discov. 2010 Sep;9(9):719-27. doi: 10.1038/nrd3074. Epub 2010 Aug 20. Review.

PMID:
20725094
14.

Melanin externalization in Candida albicans depends on cell wall chitin structures.

Walker CA, Gómez BL, Mora-Montes HM, Mackenzie KS, Munro CA, Brown AJ, Gow NA, Kibbler CC, Odds FC.

Eukaryot Cell. 2010 Sep;9(9):1329-42. doi: 10.1128/EC.00051-10. Epub 2010 Jun 11.

15.

Synthesis and in vitro and in vivo antifungal activity of the hydroxy metabolites of saperconazole.

Meerpoel L, Heeres J, Backx LJ, Van der Veken LJ, Hendrickx R, Corens D, De Groot A, Leurs S, Van der Eycken L, Weerts J, Luyts P, Van Gerven F, Woestenborghs FA, Van Breda A, Oris M, van Dorsselaer P, Willemsens GH, Bellens D, Marichal PJ, Vanden Bossche HF, Odds FC.

ChemMedChem. 2010 May 3;5(5):757-69. doi: 10.1002/cmdc.201000040.

PMID:
20379992
16.

A multifunctional mannosyltransferase family in Candida albicans determines cell wall mannan structure and host-fungus interactions.

Mora-Montes HM, Bates S, Netea MG, Castillo L, Brand A, Buurman ET, Díaz-Jiménez DF, Jan Kullberg B, Brown AJ, Odds FC, Gow NA.

J Biol Chem. 2010 Apr 16;285(16):12087-95. doi: 10.1074/jbc.M109.081513. Epub 2010 Feb 17.

17.

Genetic dissection of azole resistance mechanisms in Candida albicans and their validation in a mouse model of disseminated infection.

MacCallum DM, Coste A, Ischer F, Jacobsen MD, Odds FC, Sanglard D.

Antimicrob Agents Chemother. 2010 Apr;54(4):1476-83. doi: 10.1128/AAC.01645-09. Epub 2010 Jan 19.

18.

Editorial: Resistance to antifungal agents.

Odds FC.

Fungal Genet Biol. 2010 Feb;47(2):190. doi: 10.1016/j.fgb.2009.12.005. Epub 2009 Dec 21. No abstract available.

PMID:
20026235
19.

Molecular phylogenetics and epidemiology of Candida albicans.

Odds FC.

Future Microbiol. 2010 Jan;5(1):67-79. doi: 10.2217/fmb.09.113. Review.

PMID:
20020830
20.

Candida albicans: fundamental research on an opportunistic human pathogen.

Calderone R, Odds FC, Boekhout T.

FEMS Yeast Res. 2009 Oct;9(7):971-2. No abstract available.

21.

In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.

Odds FC.

FEMS Yeast Res. 2009 Oct;9(7):1091-101. doi: 10.1111/j.1567-1364.2009.00577.x. Epub 2009 Sep 7.

22.

Glucose promotes stress resistance in the fungal pathogen Candida albicans.

Rodaki A, Bohovych IM, Enjalbert B, Young T, Odds FC, Gow NA, Brown AJ.

Mol Biol Cell. 2009 Nov;20(22):4845-55. doi: 10.1091/mbc.E09-01-0002. Epub 2009 Sep 16.

23.

Early-expressed chemokines predict kidney immunopathology in experimental disseminated Candida albicans infections.

MacCallum DM, Castillo L, Brown AJ, Gow NA, Odds FC.

PLoS One. 2009 Jul 29;4(7):e6420. doi: 10.1371/journal.pone.0006420.

24.

Pyrosequencing analysis of 20 nucleotides of internal transcribed spacer 2 discriminates Candida parapsilosis, Candida metapsilosis, and Candida orthopsilosis.

Borman AM, Linton CJ, Oliver D, Palmer MD, Szekely A, Odds FC, Johnson EM.

J Clin Microbiol. 2009 Jul;47(7):2307-10. doi: 10.1128/JCM.00240-09. Epub 2009 Apr 29.

25.

Property differences among the four major Candida albicans strain clades.

MacCallum DM, Castillo L, Nather K, Munro CA, Brown AJ, Gow NA, Odds FC.

Eukaryot Cell. 2009 Mar;8(3):373-87. doi: 10.1128/EC.00387-08. Epub 2009 Jan 16.

26.

Genome-wide analysis of Candida albicans gene expression patterns during infection of the mammalian kidney.

Walker LA, Maccallum DM, Bertram G, Gow NA, Odds FC, Brown AJ.

Fungal Genet Biol. 2009 Feb;46(2):210-9. doi: 10.1016/j.fgb.2008.10.012. Epub 2008 Nov 6.

27.

Secreted proteinases and Candida albicans virulence.

Odds FC.

Microbiology. 2008 Nov;154(Pt 11):3245-6. doi: 10.1099/mic.0.2008/023671-0. No abstract available.

PMID:
18957578
28.

Mixed Candida albicans strain populations in colonized and infected mucosal tissues.

Jacobsen MD, Duncan AD, Bain J, Johnson EM, Naglik JR, Shaw DJ, Gow NA, Odds FC.

FEMS Yeast Res. 2008 Dec;8(8):1334-8. doi: 10.1111/j.1567-1364.2008.00438.x. Epub 2008 Sep 15.

29.

Cell wall glycans and soluble factors determine the interactions between the hyphae of Candida albicans and Pseudomonas aeruginosa.

Brand A, Barnes JD, Mackenzie KS, Odds FC, Gow NA.

FEMS Microbiol Lett. 2008 Oct;287(1):48-55. doi: 10.1111/j.1574-6968.2008.01301.x. Epub 2008 Aug 2.

30.

Multilocus sequence typing of Candida albicans isolates from animals.

Jacobsen MD, Bougnoux ME, d'Enfert C, Odds FC.

Res Microbiol. 2008 Jul-Aug;159(6):436-40. doi: 10.1016/j.resmic.2008.05.003. Epub 2008 Jun 17.

PMID:
18653318
31.

Mitochondrial haplotypes and recombination in Candida albicans.

Jacobsen MD, Rattray AM, Gow NA, Odds FC, Shaw DJ.

Med Mycol. 2008 Nov;46(7):647-54. doi: 10.1080/13693780801986631.

PMID:
18608923
32.

Multilocus sequence typing confirms synonymy but highlights differences between Candida albicans and Candida stellatoidea.

Jacobsen MD, Boekhout T, Odds FC.

FEMS Yeast Res. 2008 Aug;8(5):764-70. doi: 10.1111/j.1567-1364.2008.00392.x. Epub 2008 Jun 10.

33.

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Muñoz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE; European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Clin Infect Dis. 2008 Jun 15;46(12):1813-21. doi: 10.1086/588660.

34.

Multilocus sequence typing of pathogenic Candida species.

Odds FC, Jacobsen MD.

Eukaryot Cell. 2008 Jul;7(7):1075-84. doi: 10.1128/EC.00062-08. Epub 2008 May 2. Review. No abstract available.

35.

Molecular phylogenetic analysis of Candida tropicalis isolates by multi-locus sequence typing.

Jacobsen MD, Davidson AD, Li SY, Shaw DJ, Gow NA, Odds FC.

Fungal Genet Biol. 2008 Jun;45(6):1040-2. doi: 10.1016/j.fgb.2008.03.011. Epub 2008 Mar 25.

PMID:
18440253
36.

Animal models of mucosal Candida infection.

Naglik JR, Fidel PL Jr, Odds FC.

FEMS Microbiol Lett. 2008 Jun;283(2):129-39. doi: 10.1111/j.1574-6968.2008.01160.x. Epub 2008 Apr 16. Review.

37.

Carnitine-dependent transport of acetyl coenzyme A in Candida albicans is essential for growth on nonfermentable carbon sources and contributes to biofilm formation.

Strijbis K, van Roermund CW, Visser WF, Mol EC, van den Burg J, MacCallum DM, Odds FC, Paramonova E, Krom BP, Distel B.

Eukaryot Cell. 2008 Apr;7(4):610-8. doi: 10.1128/EC.00017-08. Epub 2008 Feb 15.

38.

Candida albicans GRX2, encoding a putative glutaredoxin, is required for virulence in a murine model.

Chaves GM, Bates S, Maccallum DM, Odds FC.

Genet Mol Res. 2007 Oct 5;6(4):1051-63.

39.

Comparison of Candida albicans strain types among isolates from three countries.

Takakura S, Ichiyama S, Bain JM, Davidson AD, Jacobsen MD, Shaw DJ, Gow NA, Odds FC.

Int J Med Microbiol. 2008 Oct;298(7-8):663-8. doi: 10.1016/j.ijmm.2007.11.002. Epub 2007 Dec 31.

PMID:
18165151
40.

Azole antifungals induce up-regulation of SAP4, SAP5 and SAP6 secreted proteinase genes in filamentous Candida albicans cells in vitro and in vivo.

Barelle CJ, Duncan VM, Brown AJ, Gow NA, Odds FC.

J Antimicrob Chemother. 2008 Feb;61(2):315-22. Epub 2007 Nov 22.

PMID:
18033783
41.

Immune recognition of Candida albicans beta-glucan by dectin-1.

Gow NA, Netea MG, Munro CA, Ferwerda G, Bates S, Mora-Montes HM, Walker L, Jansen T, Jacobs L, Tsoni V, Brown GD, Odds FC, Van der Meer JW, Brown AJ, Kullberg BJ.

J Infect Dis. 2007 Nov 15;196(10):1565-71. Epub 2007 Oct 31.

42.

Endoplasmic reticulum alpha-glycosidases of Candida albicans are required for N glycosylation, cell wall integrity, and normal host-fungus interaction.

Mora-Montes HM, Bates S, Netea MG, Díaz-Jiménez DF, López-Romero E, Zinker S, Ponce-Noyola P, Kullberg BJ, Brown AJ, Odds FC, Flores-Carreón A, Gow NA.

Eukaryot Cell. 2007 Dec;6(12):2184-93. Epub 2007 Oct 12.

43.

Infection-related gene expression in Candida albicans.

Brown AJ, Odds FC, Gow NA.

Curr Opin Microbiol. 2007 Aug;10(4):307-13. Epub 2007 Aug 17. Review.

PMID:
17707687
44.

Personal opinion: Can antifungal sensitivity tests predict clinical treatment outcomes?

Odds FC.

Rev Iberoam Micol. 1997 Sep;14(3):83-4. No abstract available.

45.

One year prospective survey of Candida bloodstream infections in Scotland.

Odds FC, Hanson MF, Davidson AD, Jacobsen MD, Wright P, Whyte JA, Gow NA, Jones BL.

J Med Microbiol. 2007 Aug;56(Pt 8):1066-75.

46.

Molecular phylogenetics of Candida albicans.

Odds FC, Bougnoux ME, Shaw DJ, Bain JM, Davidson AD, Diogo D, Jacobsen MD, Lecomte M, Li SY, Tavanti A, Maiden MC, Gow NA, d'Enfert C.

Eukaryot Cell. 2007 Jun;6(6):1041-52. Epub 2007 Apr 6.

47.

Multiple functions of DOA1 in Candida albicans.

Kunze D, MacCallum D, Odds FC, Hube B.

Microbiology. 2007 Apr;153(Pt 4):1026-41.

PMID:
17379712
48.

Multilocus sequence typing of the pathogenic fungus Aspergillus fumigatus.

Bain JM, Tavanti A, Davidson AD, Jacobsen MD, Shaw D, Gow NA, Odds FC.

J Clin Microbiol. 2007 May;45(5):1469-77. Epub 2007 Mar 21.

49.

Candida albicans Iff11, a secreted protein required for cell wall structure and virulence.

Bates S, de la Rosa JM, MacCallum DM, Brown AJ, Gow NA, Odds FC.

Infect Immun. 2007 Jun;75(6):2922-8. Epub 2007 Mar 19.

50.

Niche-specific activation of the oxidative stress response by the pathogenic fungus Candida albicans.

Enjalbert B, MacCallum DM, Odds FC, Brown AJ.

Infect Immun. 2007 May;75(5):2143-51. Epub 2007 Mar 5.

Supplemental Content

Support Center